Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Recruiting Phase 1 / 2 Trials for Pevonedistat (DB11759)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03862157Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaTreatment